ClinicalTrials.Veeva

Menu
I

Integrity Advanced Therapeutics | Houston, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

RO7790121
Trosunilimab
LY4268989
Risankizumab
Vedolizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 7 total trials
Locations recently updated

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting (PANORAMA)

Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from...

Enrolling
Ulcerative Colitis
Crohn's Disease
Drug: Vedolizumab SC
Drug: Vedolizumab IV

This Phase III, multicenter, double-blind, placebo-controlled, treat-through study will evaluate the efficacy and safety of Afimkibart (RO7790121) co...

Active, not recruiting
Moderately to Severely Active Ulcerative Colitis
Drug: Afimkibart
Drug: Placebo

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (RO779...

Enrolling
Moderately to Severely Active Ulcerative Colitis
Drug: Afimkibart
Drug: Placebo

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (also...

Enrolling
Moderately to Severely Active Crohns Disease
Drug: Placebo
Drug: Afimkibart

The main purpose of this study is to evaluate the safety and effectiveness of LY4268989 when compared to placebo in adult participants with moderatel...

Enrolling
Ulcerative Colitis (UC)
Ulcerative Colitis, Active Severe
Drug: Placebo
Drug: LY4268989
Locations recently updated

Crohn's disease (CD) and Ulcerative colitis (UC) are 2 types of inflammatory bowel diseases which cause long-lasting, severe inflammation (redness, s...

Enrolling
Ulcerative Colitis
Crohn's Disease
Drug: ABBV-701
Drug: Risankizumab

Trial sponsors

Roche logo
AbbVie logo
G
Lilly logo
Takeda logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems